73 related articles for article (PubMed ID: 20056547)
1. Design, synthesis and in vitro characterization of Glucagon-Like Peptide-1 derivatives for pancreatic beta cell imaging by SPECT.
Behnam Azad B; Rota VA; Breadner D; Dhanvantari S; Luyt LG
Bioorg Med Chem; 2010 Feb; 18(3):1265-72. PubMed ID: 20056547
[TBL] [Abstract][Full Text] [Related]
2. Progesterone receptor membrane component 1 is a functional part of the glucagon-like peptide-1 (GLP-1) receptor complex in pancreatic β cells.
Zhang M; Robitaille M; Showalter AD; Huang X; Liu Y; Bhattacharjee A; Willard FS; Han J; Froese S; Wei L; Gaisano HY; Angers S; Sloop KW; Dai FF; Wheeler MB
Mol Cell Proteomics; 2014 Nov; 13(11):3049-62. PubMed ID: 25044020
[TBL] [Abstract][Full Text] [Related]
3. Characterization of [¹²⁵I]GLP-1(9-36), a novel radiolabeled analog of the major metabolite of glucagon-like peptide 1 to a receptor distinct from GLP1-R and function of the peptide in murine aorta.
Kuc RE; Maguire JJ; Siew K; Patel S; Derksen DR; Margaret Jackson V; O'Shaughnessey KM; Davenport AP
Life Sci; 2014 May; 102(2):134-8. PubMed ID: 24641952
[TBL] [Abstract][Full Text] [Related]
4. Identifying glucagon-like peptide-1 mimetics using a novel functional reporter gene high-throughput screening assay.
Chen J; Bai G; Yang Y; Geng P; Cao Y; Zhu Y
Peptides; 2007 Apr; 28(4):928-34. PubMed ID: 17267075
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of conformationally constrained glucagon-like peptide-1 derivatives with increased plasma stability and prolonged in vivo activity.
Miranda LP; Winters KA; Gegg CV; Patel A; Aral J; Long J; Zhang J; Diamond S; Guido M; Stanislaus S; Ma M; Li H; Rose MJ; Poppe L; Véniant MM
J Med Chem; 2008 May; 51(9):2758-65. PubMed ID: 18412318
[TBL] [Abstract][Full Text] [Related]
6. New screening strategy and analysis for identification of allosteric modulators for glucagon-like peptide-1 receptor using GLP-1 (9-36) amide.
Nakane A; Gotoh Y; Ichihara J; Nagata H
Anal Biochem; 2015 Dec; 491():23-30. PubMed ID: 26341912
[TBL] [Abstract][Full Text] [Related]
7. Dual-purpose linker for alpha helix stabilization and imaging agent conjugation to glucagon-like peptide-1 receptor ligands.
Zhang L; Navaratna T; Liao J; Thurber GM
Bioconjug Chem; 2015 Feb; 26(2):329-37. PubMed ID: 25594741
[TBL] [Abstract][Full Text] [Related]
8. The identification of novel proteins that interact with the GLP-1 receptor and restrain its activity.
Huang X; Dai FF; Gaisano G; Giglou K; Han J; Zhang M; Kittanakom S; Wong V; Wei L; Showalter AD; Sloop KW; Stagljar I; Wheeler MB
Mol Endocrinol; 2013 Sep; 27(9):1550-63. PubMed ID: 23864651
[TBL] [Abstract][Full Text] [Related]
9. Taspoglutide, an analog of human glucagon-like Peptide-1 with enhanced stability and in vivo potency.
Sebokova E; Christ AD; Wang H; Sewing S; Dong JZ; Taylor J; Cawthorne MA; Culler MD
Endocrinology; 2010 Jun; 151(6):2474-82. PubMed ID: 20382695
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of optical and PET GLP-1 peptide analogues for GLP-1R imaging.
Behnam Azad B; Rota V; Yu L; McGirr R; St Amant AH; Lee TY; Dhanvantari S; Luyt LG
Mol Imaging; 2015; 14():. PubMed ID: 25762192
[TBL] [Abstract][Full Text] [Related]
11. A Duplexed High-Throughput Screen to Identify Allosteric Modulators of the Glucagon-Like Peptide 1 and Glucagon Receptors.
Morris LC; Days EL; Turney M; Mi D; Lindsley CW; Weaver CD; Niswender KD
J Biomol Screen; 2014 Jul; 19(6):847-58. PubMed ID: 24525870
[TBL] [Abstract][Full Text] [Related]
12. Glucagon-like peptide 1 prevents reactive oxygen species-induced endothelial cell senescence through the activation of protein kinase A.
Oeseburg H; de Boer RA; Buikema H; van der Harst P; van Gilst WH; Silljé HH
Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1407-14. PubMed ID: 20448207
[TBL] [Abstract][Full Text] [Related]
13. Insertion of an N-terminal 6-aminohexanoic acid after the 7 amino acid position of glucagon-like peptide-1 produces a long-acting hypoglycemic agent.
Doyle ME; Greig NH; Holloway HW; Betkey JA; Bernier M; Egan JM
Endocrinology; 2001 Oct; 142(10):4462-8. PubMed ID: 11564711
[TBL] [Abstract][Full Text] [Related]
14. A strategy for fusion expression and preparation of functional glucagon-like peptide-1 (GLP-1) analogue by introducing an enterokinase cleavage site.
Liu Y; Ren L; Ge L; Cui Q; Cao X; Hou Y; Bai F; Bai G
Biotechnol Lett; 2014 Aug; 36(8):1675-80. PubMed ID: 24737080
[TBL] [Abstract][Full Text] [Related]
15. Fc fusion to glucagon-like peptide-1 inhibits degradation by human DPP-IV, increasing its half-life in serum and inducing a potent activity for human GLP-1 receptor activation.
Kim DM; Chu SH; Kim S; Park YW; Kim SS
BMB Rep; 2009 Apr; 42(4):212-6. PubMed ID: 19403044
[TBL] [Abstract][Full Text] [Related]
16. Small molecule allosteric modulation of the glucagon-like Peptide-1 receptor enhances the insulinotropic effect of oxyntomodulin.
Willard FS; Wootten D; Showalter AD; Savage EE; Ficorilli J; Farb TB; Bokvist K; Alsina-Fernandez J; Furness SG; Christopoulos A; Sexton PM; Sloop KW
Mol Pharmacol; 2012 Dec; 82(6):1066-73. PubMed ID: 22930710
[TBL] [Abstract][Full Text] [Related]
17. Desensitization and phosphorylation of the glucagon-like peptide-1 (GLP-1) receptor by GLP-1 and 4-phorbol 12-myristate 13-acetate.
Widmann C; Dolci W; Thorens B
Mol Endocrinol; 1996 Jan; 10(1):62-75. PubMed ID: 8838146
[TBL] [Abstract][Full Text] [Related]
18. Ligand-specificity of the rat GLP-I receptor recombinantly expressed in Chinese hamster ovary (CHO-) cells.
Fehmann HC; Jiang J; Schweinfurth J; Dörsch K; Wheeler MB; Boyd AE; Göke B
Z Gastroenterol; 1994 Apr; 32(4):203-7. PubMed ID: 8017094
[TBL] [Abstract][Full Text] [Related]
19. Differential structural properties of GLP-1 and exendin-4 determine their relative affinity for the GLP-1 receptor N-terminal extracellular domain.
Runge S; Schimmer S; Oschmann J; Schiødt CB; Knudsen SM; Jeppesen CB; Madsen K; Lau J; Thøgersen H; Rudolph R
Biochemistry; 2007 May; 46(19):5830-40. PubMed ID: 17444618
[TBL] [Abstract][Full Text] [Related]
20. Dipeptidyl peptidase 4 inhibitor sitagliptin protects endothelial function in hypertension through a glucagon-like peptide 1-dependent mechanism.
Liu L; Liu J; Wong WT; Tian XY; Lau CW; Wang YX; Xu G; Pu Y; Zhu Z; Xu A; Lam KS; Chen ZY; Ng CF; Yao X; Huang Y
Hypertension; 2012 Sep; 60(3):833-41. PubMed ID: 22868389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
